Literature DB >> 8718914

Sedation for symptom control in Japan: the importance of intermittent use and communication with family members.

T Morita1, S Inoue, S Chihara.   

Abstract

We reviewed the circumstances surrounding the use of sedation for symptom control in a Japanese hospice. Of 143 inpatients, 69 (48.3%) received sedation and died an average 3.9 days after sedation was begun. Symptoms requiring sedation included dyspnea, pain, general malaise, agitation, and nausea. In 83% of cases, those symptoms were escalating as death approached. In about one-half of the cases, sedation was carried out intermittently until the patient died. Sedation was gained by such sedatives as midazolam, morphine, and haloperidol. Side effects included suppression of the respiratory and/or circulatory system in nine cases (in four cases it caused death), and delirium in one case; tolerance and dependence were also observed in two cases. We also examined the explanation to and understanding of the patients and their family members about sedation. This experience suggested the type of communication methods that are likely to be useful in Japan. It stresses the importance of intermittent use of sedation and communication with family members. We propose criteria for sedation to improve symptom control that would be acceptable in Japan.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8718914     DOI: 10.1016/0885-3924(96)00046-2

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  13 in total

Review 1.  Practical guide to palliative sedation.

Authors:  John D Cowan; Teresa W Palmer
Journal:  Curr Oncol Rep       Date:  2002-05       Impact factor: 5.075

Review 2.  [Sedation in palliative medicine: Guidelines for the use of sedation in palliative care : European Association for Palliative Care (EAPC)].

Authors:  B Alt-Epping; T Sitte; F Nauck; L Radbruch
Journal:  Schmerz       Date:  2010-08       Impact factor: 1.107

3.  Palliative sedation in Latin America: survey on practices and attitudes.

Authors:  Jairo Moyano; Sofia Zambrano; César Ceballos; Carlos Miguel Santacruz; Carlos Guerrero
Journal:  Support Care Cancer       Date:  2007-12-11       Impact factor: 3.603

Review 4.  Sedation in clinical oncology.

Authors:  Manuel González Barón; César Gómez Raposo; Alvaro Pinto Marín
Journal:  Clin Transl Oncol       Date:  2005-08       Impact factor: 3.405

Review 5.  [End-of-life dilemmas].

Authors:  Vicente Valentín Maganto; Maite Murillo González
Journal:  Clin Transl Oncol       Date:  2005-08       Impact factor: 3.405

6.  Walking the line. Palliative sedation for existential distress: still a controversial issue?

Authors:  Sophie Schur; Lukas Radbruch; Eva K Masel; Dietmar Weixler; Herbert H Watzke
Journal:  Wien Med Wochenschr       Date:  2015-12-01

Review 7.  The dying patient.

Authors:  J D Cowan
Journal:  Curr Oncol Rep       Date:  2000-07       Impact factor: 5.075

Review 8.  Ethical decision making with end-of-life care: palliative sedation and withholding or withdrawing life-sustaining treatments.

Authors:  Molly L Olsen; Keith M Swetz; Paul S Mueller
Journal:  Mayo Clin Proc       Date:  2010-08-30       Impact factor: 7.616

9.  Patient and/or family controlled palliative sedation with midazolam for intractable symptom control: a case series.

Authors:  Diamanto Aretha; Eleftheria S Panteli; Panagiotis Kiekkas; Menelaos Karanikolas
Journal:  Cases J       Date:  2009-02-11

10.  [Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients : a systematic review].

Authors:  G Benze; A Geyer; B Alt-Epping; F Nauck
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.